glp 1 receptor agonists beyond their pancreatic effects the pancreas: contrasting cardiometabolic actions of GIP and GLP1 Targeting GLP-1, GIP & GCG

~12-15 hours (endogenous circulating) ~1-2 hours (plasma) ~1-2 hours (estimated) ~1 hour (58-64 minutes) Variable (multi-compound blend) ~3+ hours (estimated, plasma) Unknown (topical peptide: no systemic PK data) Unknown (topical peptide: no systemic PK data available) Unknown (oral peptide complex, no published PK data) Unknown (oral peptide complex) Unknown (topical peptide: no systemic PK data available) Unknown (topical peptide: no systemic PK data available) No systemic PK data available (topical cosmeceutical) Not measurable systemically: acts locally in the intestinal lumen and is degraded within the GI tract Not measurable (minimal systemic absorption) ~15-30 seconds (rapid degradation by kininases) 25 minutes (normal renal function)

Glutathione as a depigmenting agent

Switching to placebo at 48 hours means residual metabolic activation will be incorrectly attributed to placebo response or baseline recovery

CarniShred + Mitoburncombines L-Carnitine with 4 Trademarked fat burning powerhouse ingredients